Boule Diagnostics Competitors and Similar CompaniesClear all

Boule Diagnostics's competitors and similar companies include Owlstone Medical, Bactiguard, Enzyre and Esperto Medical.

	Boule Diagnostics Boule Diagnostics is a healthcare technology company that develops, manufactures, and sells medical devices for blood analysis.	Owlstone Medical Owlstone Medical provides medical products and services.	Bactiguard Bactiguard, a medtech company, develops and provides infection prevention solutions.	Enzyre Enzyre is a diagnostic technology company.	Esperto Medical Esperto Medical is a company that develops vital sign monitoring technologies.
Founding Date	Founding Date 1992	Founding Date 2004	Founding Date 2005	Founding Date 2016	Founding Date 2018
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare medical devices medical diagnostics medtech	Tags Healthcare Technology healthtech medical devices medical diagnostics	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Technology healthtech medical devices medical diagnostics medtech
Locations	Locations Spånga, SE HQ Moskva, RU Plantation, US	Locations Milton, GB HQ London, GB Milton, GB Westport, US	Locations Botkyrka, SE HQ	Locations Nijmegen, NL HQ	Locations Irvine, US HQ
Employees	Employees 2261% decrease	Employees 1611% increase	Employees 147	Employees 18	Employees 129% increase
Valuation ($)	Valuation ($) 26.2 m	Valuation ($) N/A	Valuation ($) 139.7 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr489.7m (FY, 2025)	Revenue (est.) £2.6m (FY, 2018)	Revenue (est.) kr215.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods kr253.3m (FY, 2025)	Cost of goods £847.6k (FY, 2018)	Cost of goods kr31.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit kr259.6m (FY, 2025)	Gross profit £1.8m (FY, 2018)	Gross profit kr194.3m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (kr3.8m) (FY, 2025)	Net income (£7.9m) (FY, 2018)	Net income (kr7.8m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 52.9k	Total funding raised $ 66.5m	Total funding raised $ 14.9m	Total funding raised N/A	Total funding raised N/A